产品名称
SF295 Human Glioblastoma Cell Line, SF295 human glioblastoma cell line is a valuable model for glioblastoma research.
application(s)
cell analysis
Biochem/physiol Actions
Human, Cancer Cells
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Glioblastoma multiforme is the most common and malignant primary brain tumor in adults, with a high recurrence rate and a five-year survival rate of less than 5% (1). Nearly 50% of glioblastomas originate in the frontal or temporal lobes of the brain (1). Glioblastomas are the most aggressive form of cancer and demonstrate a high degree of chemotherapy resistance, highlighting the importance of relevant human patient-derived cell models for advancing research into characteristics and treatment of this disease.
SF295 is a patient-derived glioblastoma cell line originating from a temporal lobe tumor (2). SF295 cells do not express the glial markers GFAP or glutamine synthetase, but have been shown to positively express neurofibromin-1, identified as one of the most frequently mutated factors in glioblastoma multiforme (3). SF295 cells exhibit hypertriploidy and glial-like morphology in culture and are non-tumorigenic in athymic mice (2). The SF295 cell line is highly published in studies of chemotherapeutic treatments for glioblastoma, representing a valuable cellular model for assessment of drugs and molecular modulators for their effect on glioblastomas.
<bold>Source:</bold>
The SF295 glioblastoma cell line was derived from the left frontal lobe tumor of a 67-year-old female patient (2).
Research Category:
Cancer
SF295 is a patient-derived glioblastoma cell line originating from a temporal lobe tumor (2). SF295 cells do not express the glial markers GFAP or glutamine synthetase, but have been shown to positively express neurofibromin-1, identified as one of the most frequently mutated factors in glioblastoma multiforme (3). SF295 cells exhibit hypertriploidy and glial-like morphology in culture and are non-tumorigenic in athymic mice (2). The SF295 cell line is highly published in studies of chemotherapeutic treatments for glioblastoma, representing a valuable cellular model for assessment of drugs and molecular modulators for their effect on glioblastomas.
<bold>Source:</bold>
The SF295 glioblastoma cell line was derived from the left frontal lobe tumor of a 67-year-old female patient (2).
Research Category:
Cancer
Other Notes
This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
Packaging
≥1X106 cells/vial
Preparation Note
Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
212.0 °F
flash_point_c
100 °C
法规信息
高风险级别生物产品-Merck
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持